Roxatidine- and cimetidine-induced angiogenesis inhibition suppresses growth of colon cancer implants in syngeneic mice

Journal of Pharmacological Sciences

Volumn 93, Issue 3, 2003, Pages 321-330

  Tomita, Kazuyoshi ^a   Izumi, Kazuki ^a   Okabe, Susumu ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Colon cancer; Histamine; Histamine H2 receptor antagonist; Tumor suppression

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CIMETIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; ROXATIDINE ACETATE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER TRANSPLANTATION; CELL GROWTH; COLON CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; HISTOCHEMISTRY; HISTOLOGY; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TUMOR VOLUME;

ANGIOGENESIS INHIBITORS; ANIMALS; CELL LINE, TUMOR; CIMETIDINE; COLONIC NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; PIPERIDINES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0346875540     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.93.321     Document Type: Article

References (31)

1. Watanabe T, Timmerman H, Yanai K. Histamine research in the new millennium. Proceedings of the International Sendai Histamine Symposium; 2000 Nov 22 - 25; Sendai, Japan. Amsterdam: Elsevier Science B.V.; 2001.
2. Tonnessen H, Knigge U, Bulow S, et al. Effect of cimetidine on survival after gastric cancer. Lancet. 1988;2:990-992.
3. Morris DL, Adams WJ. Cimetidine and colorectal cancer - Old drug, new use? Nat Med. 1995;1:1243-1244.
4. Bolton E, King J, Morris DL. H2-antagonists in the treatment of colon and breast cancer. Semin Cancer Biol 2000;10:3-10.
5. Eaton D, Hawkins RE. Cimetidine in colorectal cancer - Are the effects immunological or adhesion-mediated? Br J Cancer. 2002;86:159-160.
6. Matsumoto S, Imaeda Y, Umemoto S, Kobayashi K, Suzuki H, Okamoto T. Cimetidine increases survival or colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells. Br J Cancer. 2002;86:161-167.
7. Hellstrand K, Naredi P, Lindner P, et al. Histamine in immunotherapy of advanced melanoma: A pilot study. Cancer Immunol Immunother. 1994;39:416-419.
8. Adams WJ, Morris DL. Short-course cimetidine and survival with colorectal cancer. Lancet. 1994;344:1768-1769.
9. Langman MJ, Dunn JA, Whiting JL, et al. Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer. British Stomach Cancer Group. Br J Cancer. 1999;81:1356-1362.
10. Jutel M, Watanabe T, Klunker S, et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature. 2001;413:420-425.
11. Lawson JA, Adams WJ, Morris DL. Ranitidine and cimetidine differ in their in vivo and in vivo effects on human colonic cancer growth. Br J Cancer. 1996;73:872-876.
12. Kobayashi K, Matsumoto S, Morishima T, Kawabe T, Okamoto T. Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression. Cancer Res. 2000;60:3978-3984.
13. Griffioen AW, Molema G. Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev. 2000;52:237-268.
14. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2002;29:15-18.
15. Janik P, Briand P, Hartmann NR. The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors. Cancer Res. 1975;35:3698-3704.
16. Adams WJ, Lawson JA, Morris DL. Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut. 1994;35:1632-1636.
17. 2 receptor-mediated modulation of local cytokine expression in a mouse experimental tumor model. Biochem Biophys Res Commun. 2002;297:1205-1210.
18. Takahashi K, Tanaka S, Ichikawa A. Effect of cimetidine on intratumoral cytokine expression in an experimental tumor. Biochem Biophys Res Commun. 2001;281:1113-1119.
19. Bartholeyns J, Fozard J. Role of histamine in tumor development. Trends Pharmacol Sci. 1985;6:123-125.
20. Rivera ES, Cricco GP, Engel NI, Fitzsimons CP, Martin GA, Bergoc RM. Histamine as an autocrine growth factor: An unusual role for a widespread mediator. Semin Cancer Biol. 2000;10:15-23.
21. Norrby K. Mast cells and angiogenesis. Apmis. 2002;110:355-371.
22. Falus A, Meretey K. Histamine: An early messenger in inflammatory and immune reactions. Immunol Today. 1992;13:154-156.
23. Fukumura D, Xavier R, Sugiura T, et al. Tumor induction of VEGF promoter activity in stromal cells. Cell. 1998;94:715-725.
24. Lazar-Molnar E, Hegyesi H, Toth S, Falus A. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine. 2000;12:547-554.
25. Shibuya M. Role of VEGF-flt receptor system in normal and tumor angiogenesis. Adv Cancer Res. 1995;67:281-316.
26. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997;18:4-25.
27. Millauer B, Longhi MP, Plate KH, et al. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res. 1996;56:1615-1620.
28. Niethammer AG, Xiang R, Becker JC, et al. A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nat Med. 2002;8:1369-1375.
29. 2 receptors. Br J Pharmacol. 2001;134:1419-1428.
30. Amano H, Ando K, Minamida S, et al. Adenylate cyclase/protein kinase A signaling pathway enhances angiogenesis through induction of vascular endothelial growth factor in vivo. Jpn J Pharmacol. 2001;87:181-188.
31. Sartippour MR, De Leon E, Rubio R, Brooks MN. The effect of commonly used drugs on angiogenesis. Anticancer Res. 2003;23:231-234.